Latest United States News

Codeifai has completed its transition to commercialisation with four self-service SaaS products live, driving a 16% revenue increase and 58% cut in operational costs in Q2 2026.

Bio-Gene Technology broadens its mosquito control program into Asia targeting key disease vectors, advances regulatory studies, and clinches a US patent extending Flavocide protection to 2040.

Boresight Ltd (ASX: BST) marked its ASX debut in June with a successful $8 million IPO, reporting a 55% revenue increase in FY26 and securing a major US manufacturing expansion to meet rising defence drone demand.

Environmental Clean Technologies expanded its PFAS destruction technology to water treatment, completed a powerful pilot system, and initiated a US OTCQB listing process.

Neurotech International has secured FDA clearance for its NTI164 Investigational New Drug application and obtained Notices of Allowance for two US patents, advancing its Phase 3 autism spectrum disorder program.

Argosy Minerals has made significant strides in its 12ktpa Rincon Lithium Project, delivering encouraging process testwork results and securing critical 40MW energy infrastructure, while engaging strategic partners for funding.

Vanadium Resources pivots to a co-production V-Iron Plant at Steelpoortdrift, securing a non-binding offtake with US Vanadium and appointing Rand Merchant Bank to drive project financing.

Orbital Corporation broadened its international footprint with new UAV propulsion orders across the US, India, and Middle East, while advancing its Power by the Hour service to underpin recurring revenue streams.

Meteoric Resources has completed a Definitive Feasibility Study for its Caldeira Rare Earth Project in Brazil, revealing a large, high-grade ionic clay deposit with a 20-plus year mine life and strong financial metrics.

Fortuna Metals has declared a maiden mineral resource at its Mkanda project in Malawi, ranking it among the top six rutile deposits worldwide, while locking in a strategic US investment of A$8.6 million from WNDR to boost market exposure.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

G50 Corp has raised A$26.25 million through a well-supported institutional placement, with Hancock Prospecting taking a significant stake. The funds will accelerate drilling and metallurgical work at its Golconda and White Caps projects in the United States.